Grau C, Johansen L V, Jakobsen J, Geertsen P F, Andersen E V, Jensen B B
Arhus Universitetshospital, Arhus Kommunehospital, onkologisk afdeling.
Ugeskr Laeger. 2001 Mar 5;163(10):1432-6.
The management of patients with cervical lymph node metastases from unknown primary tumours is a major challenge in oncology. This study presents data collected from all five oncology centres in Denmark.
Of the 352 consecutive patients with squamous cell or undifferentiated tumours seen from 1975 to 1995, a total of 277 (79%) were treated with radical intent. Most patients received radiotherapy to both sides of the neck as well as elective irradiation of the mucosal sites in nasopharynx, oropharynx, hypopharynx and larynx (81%). Irradiation of the ipsilateral neck only was done in 26 patients (10%). Radical surgery was the only treatment in 23 N1-N2 patients (9%).
The five-year estimates of neck control, disease-specific survival and overall survival for radically treated patients were 51%, 48% and 36%, respectively. The emergence of the occult primary was observed in 66 patients (19%). About half of the emerging primaries were within the head and neck region with oropharynx, hypopharynx and oral cavity being the most common sites. Emerging primaries outside the head and neck region were primarily located in the lung (19 patients) and oesophagus (five patients). The most important factor for neck control was nodal stage (5-year estimates 69% [N1], 58% [N2] and 30% [N3]). Other important parameters for neck control and disease-specific survival included haemoglobin, gender and overall treatment time. Patients treated with ipsilateral radiotherapy had a relative risk of recurrence in the head and neck region of 1.9 compared to patients treated at both neck and mucosa. At five years, the estimated control rates were 27% (ipsilateral) and 51% (bilateral; p = 0.05). The 5-year disease-specific survival estimates were 28% and 45%, respectively (p = 0.10).
Extensive irradiation to both sides of the neck and the mucosa in the entire pharyngeal axis and larynx resulted in significantly fewer loco-regional failures compared to patients treated with ipsilateral techniques, but only a trend towards better survival. Determination of the optimal strategy in terms of loco-regional control, survival and morbidity requires a prospective randomized trial.
未知原发肿瘤的颈部淋巴结转移患者的管理是肿瘤学中的一项重大挑战。本研究展示了从丹麦所有五个肿瘤中心收集的数据。
在1975年至1995年间连续就诊的352例鳞状细胞或未分化肿瘤患者中,共有277例(79%)接受了根治性治疗。大多数患者接受了双侧颈部放疗以及鼻咽、口咽、下咽和喉部黏膜部位的选择性照射(81%)。仅对同侧颈部进行照射的有26例患者(10%)。23例N1 - N2患者(9%)仅接受了根治性手术。
接受根治性治疗患者的颈部控制、疾病特异性生存和总生存的五年估计率分别为51%、48%和36%。66例患者(19%)发现了隐匿性原发灶。大约一半的新发原发灶位于头颈部区域,口咽、下咽和口腔是最常见的部位。头颈部区域以外的新发原发灶主要位于肺(19例患者)和食管(5例患者)。颈部控制的最重要因素是淋巴结分期(五年估计率:N1为69%,N2为58%,N3为30%)。颈部控制和疾病特异性生存的其他重要参数包括血红蛋白、性别和总治疗时间。与接受双侧颈部和黏膜治疗的患者相比,接受同侧放疗的患者头颈部区域复发的相对风险为1.9。五年时,估计的控制率分别为27%(同侧)和51%(双侧;p = 0.05)。五年疾病特异性生存估计率分别为28%和45%(p = 0.10)。
与采用同侧技术治疗的患者相比,对双侧颈部以及整个咽轴和喉部的黏膜进行广泛照射导致局部区域失败明显减少,但仅在生存方面有改善趋势。确定在局部区域控制、生存和发病率方面的最佳策略需要进行前瞻性随机试验。